Tier 3 · Filer Universe

Seres Therapeutics, Inc.

MCRB · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$5.30
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001609809
Liquidity rank
#4549
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$789,000.002025-12-310001193125-26-103276
Annual diluted EPS0.642025-12-310001193125-26-103276
Quarterly revenue$358,000.002026-03-310001193125-26-205434
Quarterly diluted EPS-2.082026-03-310001193125-26-205434

SEC EDGAR Frames batch generated 2026-07-16T23:27:27.073Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerTMO · Tier 1 peerPFE · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames